V
VKTX
Viking Therapeutics Inc
33.89
-0.47-1.37%After Hours: 33.91 +0.02 +0.06%19:59 08/21 EDT
OPEN/PREV CLOSE34.79/34.36
TODAY RANGE33.47-34.98
VOL1.50M
MARKET CAP3.95B
52 WEEK RANGE22.96-43.15
AVG VOL (3M)2.28M
% TURNOVER1.28%
TURNOVER--
P/E (TTM)-7.2691
% RANGE4.37%
EPS(TTM)-4.6622
P/E(FORWARD)-7.3505
P/B9.68
BVPS3.500
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.83B
SHARES OUTSTANDING116.65M
NEXT EARNINGS10/20-10/26
FREE FLOAT113.04M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·08/16 20:20
2 GLP-1 Stocks That Could Double Your Money by 2031
TipRanks·08/14 14:05
Cantor Fitzgerald Reaffirms Their Buy Rating on Viking Therapeutics (VKTX)
Dow Jones·08/11 15:00
Viking Therapeutics Is Maintained at Overweight by JP Morgan
Dow Jones·08/11 15:00
Viking Therapeutics Price Target Cut to $65.00/Share From $75.00 by JP Morgan
TipRanks·08/11 11:36
Viking Therapeutics price target lowered to $65 from $75 at JPMorgan
TipRanks·08/10 21:14
3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts
Dow Jones·08/10 20:32
Corbus Pharmaceuticals Holdings Inc. Stock Falls 7.0%, Underperforms Peers
NASDAQ·08/08 19:50
Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics?
Dow Jones·08/07 20:35
Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.4%, Outperforms Peers
Seeking Alpha·08/07 19:13
Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst Due Q3 (Q2 Earnings Overview)
TipRanks·08/06 20:06
Viking Therapeutics participates in a conference call with Cantor
Same Industry
Name/Symbol
Change%
Price